The AI workforce
Three agents. One research site.
Each takes on a function that decides whether your site grows: your patients, your studies, your budgets.
Aiden
In development
Optimize clinical trial portfolio, sponsor communication and study acquisition.
Aimee
In development
Optimize clinical trial budgets to expand revenue to research sites.
Agent 4
.
Not yet in development
This is what patients see.
Real conversations, in the patient's own language, on the device they already use.
Every patient
Every patient. Every month.
Between staff burnout from manual calls and missed opportunities from waiting until the next office visit, traditional site outreach is broken. Every patient deserves to hear about relevant trials on their own terms — in their preferred language, on the right device, at the exact time they're ready to engage.
80+
Languages supported natively at every touchpoint
Monthly
Contact cadence
24/7
Hours of operation
Any time
Patient opt-out
None
EHR access required
24 to 60%
Pre-screen for a completely different indication than the one you targeted
Every study
The patient chooses. Not your EHR and CTMS.
Let patients take control and choose the studies that interest them — not the ones your EHR and CTMS tagged them with years ago. They see every trial you have open, pulled live from ClinicalTrials.gov, and decide for themselves.
Every month
Interest isn't a moment. It's a window.
Most patients don't raise their hand on day one. They engage months later — after a diagnosis changes, a treatment fails, or life slows down. Coordinators simply don't have the bandwidth to nurture thousands of patients over a 12-month timeline. Jane stays in touch so your site is there the exact moment their situation changes.
Up to 14 months
Before a patient decides to consider a clinical trial
Patient-to-patient referrals
Your patients bring you patients.
Patients don't trust health information from mass media. They trust the people around them — and each one sits at the center of a network of one to five others with a similar condition. Online ads keep resurfacing the audiences you've already reached. Referrals reach people who were never in your reach at all.
134%
Increase in trial enrollment from patient-to-patient referrals when referring patients are compensated
You choose whether to pay, and how much. Researchify generates the links, runs the monthly prompts, attributes every referral, and disburses payment on your behalf once you confirm.
Your site stays the payer of record. W-9s and SSNs never enter our system — we hold only your attestation that one is on file, track cumulative totals against the IRS threshold, and hand you the year-end figures.
Organic
No compensation
Patients share your trials with friends and family because they want to.
Per new patient
~$25
Paid when someone they refer joins your patient population.
Per enrollment
~$100
Paid only once the referred patient qualifies and enrolls in a study.
Pre-screening
Patients medical conditions and medications are highly dynamic.
Patients see outside doctors, start new medications, and develop new conditions between visits — data static EHR charts simply miss. Jane gets it directly from the patient, not from your EHR: a live, 360-degree clinical picture from the source. Patients consent by responding, share what they choose, and opt out anytime — giving you today's reality, not last year's office visit.
.png)
.png)
Medications
Current and prior prescriptions, doses, classes, therapy changes and duration. Prohibited medications flagged against each protocol.
Comorbidities and history
Diagnosed conditions, related conditions and disease progression — the history a single indication code never captures.
Upcoming procedures
Planned or recent surgeries, joint replacements and bariatric procedures that determine eligibility.
Remote clinical assessment · patent pending
Patients don't type it. They photograph it.
Medication bottles, inhalers and injectables. Lab reports and pathology results. Discharge paperwork. Glucose meters and blood pressure cuffs. Affected skin, nails and wounds. Jane reads all of it and turns it into structured data your coordinators can act on.
Seconds
From photograph to structured clinical data
.png)
Patient Digital Pre-Screening
He asked about one trial. Jane found him a better one at your site.
A 68-year-old man saw an obesity study on his site's trial page and entered his phone number. Thirteen questions later, Jane had his height and weight, his knee pain score, how long ago he was diagnosed, the injection he'd had, and the two medications he takes.
The obesity study he chose came back fourth — his age and BMI both fell outside its range. The strongest match was a knee osteoarthritis trial he never asked about, and never would have found on his own: 25 criteria met, none failed.
One submission. Seven protocols assessed. 147 criteria resolved one at a time.
From the site's report. Site-facing only — patients never see it, and your PI or coordinator makes the final determination.
Jane's results
What Jane changes at a
research site.
$400K–$2.1M
Additional research revenue, per location per year
Sites enroll 31% to 59% more patients — without new advertising, new referral sources, or added staff.
Hundreds of hours
Returned to your team every month
Outreach, follow-up and pre-screening run around the clock. 43% of patient submissions arrive after hours or at weekends, when no coordinator is on the phone.
Every patient
Hears what they're eligible for
Monthly contact in 80+ languages, on the patient's own device, at the hour they choose to reply — with the option to stop at any time.
Meet Aiden
(in development, available fall 2026)
Turning pre-screen fails into new studies.
They said yes. You said "we don't have a trial."
When 70% to 85% of your patients pre-screen out, it's a protocol gap, not a patient rejection. They trusted your site enough to raise their hand. Aiden matches their data to open protocols and pitches sponsors directly to bring those exact trials straight to your site.
How Aiden works
Four steps. Zero added workload.
Your team makes one decision — which studies to pursue. Aiden does the rest.
Scan
Aiden watches the entire trial marketplace continuously — every actively recruiting study on ClinicalTrials.gov, refreshed as sponsors post and update them. Not a shortlist your team maintains by hand.
78,000+
Studies enrolling on ClinicalTrials.gov, screened against your patients
Match
Every patient who pre-screened out gets evaluated against those external protocols, criterion by criterion — the same assessment Jane runs against your own studies, pointed outward.
Compile
You get a shortlist, not a to-do list. One email: the studies that fit, the phase, the criteria that matched, and how many of your patients qualify for each. You tick the ones you want.
.png)
.png)
Contact
Aiden makes the pitch. Outreach goes to the sponsor's study team on your site's behalf, with a de-identified clinical summary attached as evidence the patients are already there. What comes back to you is a call on your calendar.
210
Patients pre-screen-failed at the site
114
Matched to at least one external sponsor study
53
Qualified for a single sponsor study alone
Meet Aimee
(in development, available fall 2026)
Negotiating stronger clinical trial budgets.
80% to 90% of research sites operate at a loss or financial breakeven.
Underpriced budgets, missed fee categories and administrative blind spots quietly drain site margins — even on fully enrolled studies. Most sites have no reliable way to see where the money is being left on the table before they sign.
How Aimee works
Seven steps. One email.
Aimee evaluates every line of your budget against protocol requirements, your site's own cost drivers and real-time market data — closing the gap between what your site is paid and what the work actually costs.
See everything
Aimee reads every procedure, visit and assessment in the protocol and the schedule of events. Nothing is estimated, sampled or assumed. Each billable item is checked against your budget, line by line.
90%
Of protocol assessment schedules are inaccurate or incomplete before a manual review
Find what's hidden
Protocol amendments and re-consenting. Complex informed consent. Extra monitoring and sponsor visits. Central lab and imaging logistics. Aimee flags the administratively heavy work that adds coordinator hours and almost never makes it into a budget line.
76%
Of trials require a substantial protocol amendment — median direct cost $141K in Phase II to $535K in Phase III
Know your market
Labor costs, cost of living, IRB fees and standard-of-care norms vary widely by geography. Aimee benchmarks your budget against comparable sites in your region — not a flat national average — using public labor-cost data and published multi-region trial cost studies.
Stay ahead of inflation
Aimee monitors clinical trial cost inflation continuously and recommends the adjustments that keep your fee structure level with it — instead of falling a little further behind with every study.
5%–7%
Average annual clinical trial cost inflation, tracked and applied to your budget automatically
Build the ask
Aimee right-sizes the one-time startup and regulatory fees, then adds the recurring lines most budgets miss entirely — built around your site's cost structure, not a template.
Make it effortless
No portals. No manual data entry. You email Aimee the draft budget and the schedule of assessments. Aimee reads both, cross-references them against the protocol, and checks everything against your site's standing profile automatically.
Bring the evidence
Aimee draws on the patient engagement and pre-screening data Jane has already collected at your site to demonstrate feasibility and enrollment velocity. Your site enters the negotiation backed by real demand, not estimates.
31%–59%
More patients enrolled at sites running Jane — the enrollment evidence Aimee brings to the table
25%–40%
Increase in startup fees — right-sized one-time and regulatory fees that reflect true site setup cost
15%–25%
Increase in per-patient fees — visit-level rates adjusted to cover actual coordinator and site time
Every line
Assessed against the protocol, your cost structure and the current market, before you sign
Ranges reflect typical outcomes across sites and studies. Actual results vary by protocol, sponsor and region.
Implementation
Live in two weeks. Nothing to manage.
01
Studies import
Your enrolling studies by NCT or protocol ID. We integrate with ClinicalTrials.gov and refresh weekly.
02
Patient import
A secure file with first name, mobile number and condition. We set up the shared drive.
03
Point of contact
Two or three email addresses for reporting, submissions and invoices.
04
Review and go
One call to review messaging and pre-screening questions, then you're live.
IRB-compliant messaging · HIPAA-validated systems · No new platform for your team to learn